A. Ari Hakimi
Impact in
- Cancer Research top 0.1%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Pulmonary and Respiratory Medicine top 0.05%
- Renal cell carcinoma treatment
- Ferroptosis and cancer prognosis
Papers in
-
- Renal cell carcinoma treatment 164
- Ferroptosis and cancer prognosis 18
-
- Cancer Genomics and Diagnostics 59
- Cancer, Hypoxia, and Metabolism 11
- Co-authors
- PAUL A. J. RUSSO (86 shared papers)James J.-D. Hsieh (52 shared papers)Martin Henner Voss (45 shared papers)Robert John Motzer (51 shared papers)Timothy An-thy Chan (16 shared papers)Victor E. Reuter (22 shared papers)Satish K. Tickoo (22 shared papers)Chris Sander (10 shared papers)
- Journals
- The Journal of Urology (34 papers)Urologic Oncology Seminars and Original Investigations (15 papers)European Urology (14 papers)Urology (12 papers)Clinical Cancer Research (9 papers)
- Partner nations
- United StatesGermanyAustralia
In The Last Decade
A. Ari Hakimi
256 papers receiving 22.7k citations
A. Ari Hakimi's Hit Papers
Peers
Comparison fields: 5 of 156
- Cancer Research 6.5k
- Pulmonary and Respiratory Medicine 9.8k
- Oncology 6.2k
- Molecular Biology 8.5k
- Immunology 2.1k
Countries citing papers authored by A. Ari Hakimi
This map shows the geographic impact of A. Ari Hakimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Ari Hakimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Ari Hakimi more than expected).
Fields of papers citing papers by A. Ari Hakimi
This network shows the impact of papers produced by A. Ari Hakimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Ari Hakimi. The network helps show where A. Ari Hakimi may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Ari Hakimi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 272 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor mutational load predicts survival after immunotherapy across multiple cancer types Hit paper breakdown → | 2019 | 3019 |
| 2 | Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients Hit paper breakdown → | 2017 | 2650 |
| 3 | Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures Hit paper breakdown → | 2016 | 738 |
| 4 | The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma Hit paper breakdown → | 2014 | 659 |
| 5 | The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma Hit paper breakdown → | 2018 | 640 |
| 6 | The head and neck cancer immune landscape and its immunotherapeutic implications Hit paper breakdown → | 2016 | 620 |
| 7 | An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma Hit paper breakdown → | 2016 | 607 |
| 8 | The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma Hit paper breakdown → | 2018 | 569 |
| 9 | Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma Hit paper breakdown → | 2019 | 549 |
| 10 | 2016 | 422 | |
| 11 | Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients Hit paper breakdown → | 2022 | 418 |
| 12 | Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma Hit paper breakdown → | 2019 | 321 |
| 13 | Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors Hit paper breakdown → | 2021 | 317 |
| 14 | 2013 | 311 | |
| 15 | 2016 | 291 | |
| 16 | Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy Hit paper breakdown → | 2021 | 288 |
| 17 | 2015 | 249 | |
| 18 | 2013 | 247 | |
| 19 | 2013 | 239 | |
| 20 | 2014 | 234 |
About A. Ari Hakimi
A. Ari Hakimi is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology, Oncology and Surgery, having authored 272 papers that have together received 22.9k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (164 papers), Cancer Genomics and Diagnostics (59 papers), Renal and related cancers (50 papers), Cancer Immunotherapy and Biomarkers (20 papers), Ferroptosis and cancer prognosis (18 papers), Bladder and Urothelial Cancer Treatments (18 papers), Epigenetics and DNA Methylation (17 papers) and Cancer, Hypoxia, and Metabolism (11 papers). The work is most often cited by research in Cancer Research (6.5k citations), Pulmonary and Respiratory Medicine (9.8k citations), Oncology (6.2k citations), Molecular Biology (8.5k citations) and Immunology (2.1k citations). A. Ari Hakimi has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include PAUL A. J. RUSSO, James J.-D. Hsieh, Martin Henner Voss, Robert John Motzer, Timothy An-thy Chan, Victor E. Reuter, Satish K. Tickoo, Chris Sander, Ying‐Bei Chen and Nadeem Riaz. Their work appears in journals such as The Journal of Urology, Urologic Oncology Seminars and Original Investigations, European Urology, Urology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.